Trial Profile
Degarelix Acetate Prior to Radiation Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Degarelix (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 10 Feb 2018 Results presented at the 2018 Genitourinary Cancers Symposium
- 04 Oct 2016 Status changed from active, no longer recruiting to completed.
- 13 Sep 2016 Status changed from recruiting to active, no longer recruiting.